TABLE 3.

Patient Characteristics and Stage in 17 Patients with Lymphoma

Patient no.	Age (y)	Sex	WF grade*	Nodal stage†	PET nodal stage		Final stage‡
Patient no.	Age (y)	Sex	WF grade*	Nodal stage†	FDG	MET	Final stage‡
1	74	M	High	II	II	I	I
2	51	F	Low	III	III	III	IV
3	63	F	Low	II	III	III	IV
4	58	F	Hodgkin	III	III	III	III
5	48	M	Hodgkin	I	II	II	I
6	70	F	Low	I	I	I	I
7	28	M	Hodgkin	II	II	II	II
8	48	F	Low	III	III	III	III
9	81	F	High	I	I	I	IV
10	50	M	Low	III	III	III	IV
11	73	F	Low	II	II	II	II
12	33	M	Low	I	I	I	I
13	33	M	Intermediate	I	I	I	I
14	47	M	Low	III	III	III	III
15	59	M	Hodgkin	II	III	III	II
16	55	F	Intermediate	III	III	II	III
17	72	M	Low	I	I	I	IV

↵* According to Working Formulation (WF) system.
↵† By conventional methods according to Ann Arbor staging system.
↵‡ By conventional methods including extranodal disease and follow-up evaluation.